AI Terminal
Ion Beam Applications, SA
Declaration of Voting Results & Voting Rights Announcements • Feb 3, 2021
3960_mrq_2021-02-03_833bbdeb-8b9b-41bd-bf5d-2968783bdf4d.pdf
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
IBA – TRANSPARENCY NOTIFICATION
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)
Louvain-la-Neuve, Belgium, February 3rd, 2021, 19.30
Summary of the notification
IBA (Ion Beam Application), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February 2 nd, 2021.
In its notification, BlackRock, Inc. has notified, that following an acquisition of voting rights, its total holding in IBA SA has crossed upwards the 1% threshold.
Content of the notification
- Reason for the notification: Acquisition or disposal of voting securities or voting rights
- Notification by : A parent undertaking or a controlling person
- Persons subject to the notification requirement:
BlackRock Inc., 55 East 52nd Street, New York, NY, 10055, U.S.A. BlackRock (Netherlands) B.V, Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock Advisors (UK) Limited, 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Asset Management Canada Limited, 161 Bay Street,, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Fund Advisors, 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National Association, 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Investment Management, LLC, 1 University Square Drive, Princeton, NJ, 8540,, U.S.A.
- Date on which the threshold is crossed: 26/01/2021
- Threshold crossed (in %): 1%
- Denominator: 38.254.747
- Notified details: (extract of the received notification form)
Press release 03/02/2021
| A) Voting rights | Previous notification | After the transaction | ||||
|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | ||||
| Holders of voting rights |
Linked to securities |
Not linked to the securities |
Linked to securities |
Not linked to the securities |
||
| BlackRock Inc. | 0 | 0 | 0.00% | |||
| BlackRock (Netherlands) B.V |
2,489 | 2,489 | 0.01% | |||
| BlackRock Advisors (UK) Limited |
26,385 | 18,401 | 0.05% | |||
| BlackRock Asset Management Canada Limited |
5,768 | 5,768 | 0.02% | |||
| BlackRock Fund Advisors |
225,432 | 226,906 | 0.59% | |||
| BlackRock Institutional Trust Company National Association |
129,083 | 108,083 | 0.28% | |||
| BlackRock Investment Management, LLC |
544 | 28 | 0.00% | |||
| Subtotal | 389,701 | 361,675 | 0,95% | |||
| TOTAL | 361,675 | 0 | 0,95% | 0,00% |
| B) Equivalent financial instruments |
After the transaction | |||||
|---|---|---|---|---|---|---|
| Holder of equivalent financial instruments |
Type of financial instrument | Expiration date |
Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights |
Settlement |
| BlackRock Advisors (UK) Limited |
Securities Lent | 16,646 | 0.04% | Physical | ||
| BlackRock Fund Advisors |
Securities Lent | 80 | 0.00% | Physical |
Press release 03/02/2021
| BlackRock Institutional Trust |
|||||
|---|---|---|---|---|---|
| Company, | Securities Lent | 27,503 | 0.07% | Physical | |
| National | |||||
| Association | |||||
| BlackRock | |||||
| Investment | Securities Lent | 516 | 0.00% | Physical | |
| Management, LLC | |||||
| TOTAL | 44,745 | 0.12% |
| TOTAL (A & B) | # of voting rights |
%of voting rights |
|---|---|---|
| 406,420 | 1.06% |
• Full chain of controlled undertakings through which the holding is effectively held
BlackRock, Inc. Trident Merger, LLC BlackRock Investment Management, LLC
BlackRock, Inc. BlackRock Holdco 2, Inc. BlackRock Financial Management, Inc. BlackRock Holdco 4, LLC BlackRock Holdco 6, LLC BlackRock Delaware Holdings Inc. BlackRock Institutional Trust Company, National Association
BlackRock, Inc. BlackRock Holdco 2, Inc. BlackRock Financial Management, Inc. BlackRock Holdco 4, LLC BlackRock Holdco 6, LLC BlackRock Delaware Holdings Inc. BlackRock Fund Advisors
BlackRock, Inc. BlackRock Holdco 2, Inc. BlackRock Financial Management, Inc. BlackRock International Holdings, Inc. BR Jersey International Holdings L.P. BlackRock Holdco 3, LLC
Press release 03/02/2021
IBA | Ion Beam Applications Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant Wallon | VAT BE0428.750.985 T +32 10 47 58 11 | F +32 10 47 58 10 | [email protected] | iba-worldwide.com
BlackRock Canada Holdings LP BlackRock Canada Holdings ULC BlackRock Asset Management Canada Limited
BlackRock, Inc. BlackRock Holdco 2, Inc. BlackRock Financial Management, Inc. BlackRock International Holdings, Inc. BR Jersey International Holdings L.P. BlackRock Holdco 3, LLC BlackRock Cayman 1 LP BlackRock Cayman West Bay Finco Limited BlackRock Cayman West Bay IV Limited BlackRock Group Limited BlackRock Finance Europe Limited BlackRock Advisors (UK) Limited
BlackRock, Inc. BlackRock Holdco 2, Inc. BlackRock Financial Management, Inc. BlackRock International Holdings, Inc. BR Jersey International Holdings L.P. BlackRock Holdco 3, LLC BlackRock Cayman 1 LP BlackRock Cayman West Bay Finco Limited BlackRock Cayman West Bay IV Limited BlackRock Group Limited BlackRock Finance Europe Limited BlackRock (Netherlands) B.V.
• Additional Information
The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 1%.
For further information, please contact:
IBA
Valérie Van Impe Paralegal +32 10 203 180
Press release 03/02/2021
[email protected]
About IBA
IBA (Ion Beam Applications) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
